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.2012.07.0Abstract The endothelium-derived hyperpolarizing factor (EDHF) response is a critical for the
functioning of small blood vessels. We investigated the effect of streptozotocin-induced diabetes
on the EDHF response and its possible role in the regulation of cardiac function. The vasorelaxant
response to ACh- or NS309- (direct opener endothelial small- (SKCa)- and intermediate-
conductance (IKCa) calcium-activated potassium channels; main components of EDHF response)
were measured in pressurized mesenteric arteries (diameter 300–350 lm). The response to 1 lM
ACh was reduced in diabetes (84.8 ± 2.8% control vs 22.5 ± 5.8% diabetics; nP 8; P< 0.001).
NS309 (1 lM) relaxations were also decreased in diabetic arteries (78.5 ± 8.7% control vs
32.1 ± 5.8% diabetics; nP 5; P< 0.001). SKCa and IKCa-mediated EDHF relaxations in response
ACh or NS309 were also signiﬁcantly reduced by diabetes. Ruthenium red, RuR, a blocker of TRP
channels, strongly depress the response to ACh and NS309 in control and diabetic arteries. RuR
decreased SKCa and IKCa-mediated EDHF vasodilatation in response to NS309 but not to ACh.
An elevation in systolic blood pressure was observed in diabetic animals. ECG recording of control
hearts showed shortening of PR interval. RuR reduced PR interval and R wave amplitude in dia-
betic hearts. In conclusion, the reduced EDHF-type relaxations in STZ-induced diabetes is due
impairment of KCa channels function. TRP channels possibly contribute to EDHF vasodilatationss: Faculty of Life Sciences,
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376 M. Absi et al.via direct opening of endothelial KCa. It is possible that EDHF and TRP channels contribute to the
regulation of cardiac function and therefore can be considered as therapeutic targets to improve
cardiovascular complications of diabetes.
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Endothelial cells have an essential role in the control of tone of
the underlying smooth muscle cells via the release of various
vasodilators [1,2]. These include nitric oxide (NO), prostacy-
clin and the endothelium-derived hyperpolarizing factor
(EDHF) [3]. Although the exact mechanism by which EDHF
acts is controversial [4,5], it is well-established that endothelial
small-conductance, (SKCa) and the intermediate-conductance,
calcium-activated potassium channel (IKCa) are essential for
the initiation of the EDHF pathway [5]. The activation of these
channels requires an increase in the intracellular Ca2+ concen-
tration [Ca2+]i of endothelial cells [6]. The hyperpolarization-
induced by the activation of endothelial KCa channels in-
creases the driving force for Ca2+ inﬂux via cation channels
belonging to transient receptor potential ion channels (TRP
channels) which sustain the Ca2+ signal [7].
The contribution of EDHF to the relaxation of blood ves-
sels depends on the size of the blood vessel being of major
importance in small arteries [8].
Complications of diabetes (such as nephropathy and reti-
nopathy) are due to dysfunction of small blood vessels [9].
Thus, the impairment of the EDHF responses could have an
important impact on the microvasculature. Indeed, Wigg
et al. [10] reported a selective impairment of the EDHF-medi-
ated relaxation in the mesenteric artery whereas Shi et al. [11]
reported an augmented contribution of EDHF and reduced
contribution of NO to endothelium-dependent relaxations.
Leo et al. [12] showed an impairment of both, NO and
EDHF-dependent relaxation of rat mesenteric arteries. These
studies showed a reduced responsiveness to the endothelium
dependent vasodilator acetylcholine (ACh) which induces the
activation of endothelial KCa channels by a global increase
in [Ca2+]i [13,14].
NS309 is a selective opener of both the SKCa and IKCa
channels acting by enhancing the sensitively of KCa channels
to intracellular Ca2+ [15]. This compound hyperpolarizes
smooth muscle cells of rat mesenteric arteries [16] and human
endothelial cells [17]. Recently, it has been demonstrated that
there is a reduction in EDHF-type relaxation upon ACh or
NS309 stimulation of mesenteric small arteries from ZDF
rat; an animal model of type II diabetes [18].
Changes in the heart rate are accompanied by alterations in
both [Ca2+]i and action potential duration (APD) [19]. The
expression of different subtypes of SKCa channels were demon-
strated in rat, murine and human hearts [20–22]. It was
hypothesized that based on the high calcium-sensitivity of
these channels, they may be involved in the modiﬁcation of
APD of cardiac tissues particularly during cardiac repolarisa-
tion. Indeed, based on the observation that the inhibition of
SKCa channels lengthens the APD, it was suggested that these
channels can represent an antiarrhythmic mechanism [21].
The aim of the present study was, therefore, to investigate
the effect of streptozotocin (STZ)-induced diabetes on the
EDHF (and its main components IKCa and SKCa)-mediatedrelaxation of mesenteric arteries using activators that work
by two different mechanisms namely ACh (by causing a global
increase in [Ca2+]i) and NS309 (acting by direct activation the
KCa channels). Both KCa channels are activated by increase in
[Ca2+]i in order to initiate EDHF pathway. Therefore, we
tested whether any change in NS309 or ACh-induced EDHF
response is due to change in Ca2+ inﬂux mechanism especially
TRP channels; one of the main pathways for Ca2+ inﬂux into
the endothelial cells. The possible role of EDHF response in
the regulation of cardiac function was also studied.
Our data suggest that the EDHF response is reduced in rats
with (STZ)-induced diabetes. This is attributed to the impair-
ment of direct opening of endothelial KCa channels. TRP
channels may be involved in the EDHF-mediated relaxations.
EDHF response contributes to the regulation of the electrical
conduction of normal hearts whereas the role of TRP channel
is more prominent in diabetic hearts.
Methodology
Animals
Animal use in the present study was approved by The Animal
Use Committee of Aleppo University and is in accordance
with the institutional regulations. Male albino Wistar rats
(220–300 g; n= 25) were maintained in the laboratory of the
animal unit of Aleppo University under standard laboratory
conditions, i.e. at 25 ± 2 C with a 12-h dark-light cycle. They
were fed with regular chow, and given free access to water.
Diabetes was induced by a single intravenous injection of
streptozotocin (STZ; 60 mg/kg of body weight, dissolved in cit-
rate buffer, pH 4.5), into the tail vein. For controls, age-
matched rats were injected with the same volume of citrate
buffer only. All experiments were performed four weeks after
the STZ injection; at that time the tail blood glucose level
was above 350 mg/dl.
Preparation of mesenteric arteries
Rats were decapitated. Small mesenteric arteries (second order
branch; approximate diameter 300–350 lm) were rapidly re-
moved and placed in ice-cold Krebs solution (composition in
mM: NaCl 119, KCl 4.7, CaCl2 2.0, KH2PO4 1.2, MgSO4
1.2, NaHCO3 25, KH2PO4 1.18, glucose 11) bubbled with
95% O2 and 5% CO2. The artery was carefully cleaned of fat
and connective tissue, and cut into segments 1–2 mm in length,
these were cannulated and mounted in the chamber of a pres-
sure myograph (Model 111P; Danish Myo Technology, Aar-
hus, Denmark) containing 10 ml of oxygenated (95% O2–5%
CO2) Krebs solution. The arteries were left for at least 30 min
to adapt before application of drugs; the intraluminal pressure
was held at 70 mm Hg and the temperature at 37 C. The exter-
nal diameter of the artery was recorded with CCD camera using
MyoView software (Danish Myo Technology, Aarhus,
Denmark). In order to study the EDHF-mediated response,
Table 1 Glucose and insulin levels, body weights, liver/body
weight, lung/body weight and heart/body ratios, both in
control and diabetic animals (n= 25). Data expressed as
mean ± SEM.
Control Diabetics
Glucose level (mg/dl) 130.8 ± 11.2 433 ± 20.1*
Insulin level (lU/ml) 19.2 ± 2.3 3.4 ± 0.3*
Body weight (g) 259 ± 11 162 ± 6.1*
Liver/body weight ratio (g) 38.4 ± 3.3 40.2 ± 2.4
Lung/body weight ratio (g) 5.0 ± 0.5 6.5 ± 0.4
Heart/body weight ratio (g) 3.5 ± 0.3 3.7 ± 0.5
* Signiﬁcantly different from the control rats (Unpaired t test,
P< 0.001).
EDHF-mediated responses in diabetic rats 377Krebs solution containing 300 lM N-nitro-L-arginine and
10 lM indomethacin (non-selective nitric oxide synthase and
cyclooxygenase inhibitors, respectively) was used throughout
the experiments. Arteries were pre-constricted with an approx-
imate EC50 concentration of phenylephrine (1 lM). KCa and
TRP channel inhibitors were applied intraluminally at least
20 min before the application of ACh or NS309.
Body weight and biochemical measurements
Body weights were determined before and after the induction
of diabetes and at the day of the experiment. Glucose levels
were measured in samples taken from blood via the tail vein
using the glucose oxidase method (BioSed, Italy). Insulin levels
were measured using Ultra Sensitive Mouse Insulin ELISA Kit
(Crystal Chem., Inc., IL, USA) with a microplate reader (Mul-
tiskan EX Microplate Photometer, Thermo Scientiﬁc, Schw-
erte, Germany).
Tail-cuff blood pressure measurements
Arterial blood pressure was measured non-invasively (Volume
Pressure Recording; using a CODA 8-channel tail-cuff blood
pressure system; Kent Scientiﬁc, Torrington, CT, USA). Blood
pressure (BP; systolic, diastolic & mean) and heart rate (HR)
measurements were performed after pre-warming the rats on
a platform kept at 37 C for 10 min. This allows to de-stressing
the rat. However, the rat which exhibits any signs of distur-
bance after 10 min (such as moving the tail) was excluded from
the study. The proximal occlusion cuff constricts the tail ar-
tery, while the distal cuff detects changes in tail artery volume
when blood ﬂow resumes as the occlusion cuff deﬂates. Mea-
surements of average of three sessions (each consisting of
15 cycles) were used for statistical analysis.
Electrocardiogram (ECG) recording
Control and diabetic rats were anaesthetized with sodium pen-
tobarbitone (50 mg kg1, i.p), were given heparin (250 IU i.v),
and were killed by cervical dislocation. Their hearts were rap-
idly excised and placed immediately into an ice-cold perfusion
buffer. These were cannulated through the aorta in a Lange-
ndorff system, perfused with oxygenated (95% O2, 5% CO2)
Krebs-Henseleit solution (composition in mM: NaCl 118.5,
KCl 4.7, CaCl2 1.8, MgSO4 1.2, KH2PO4 1.2, glucose 11.0,
NaHCO3 25.0, pH 7.4) at 37 C and allowed to stabilize for
30 min after being mounted. Initial perfusion pressure kept
constant at 80 mmHg. The isolated hearts from control and
diabetic rats were treated with: Krebs solution, Krebs solution
plus 300 lM N-nitro-L-arginine and 10 lM indomethacin (in
order to inhibit NO and prostaglandin synthesis) with and
without 1 lM ruthenium red (a non-selective blocker of TRP
channels; also known for its speciﬁc inhibition of TRPV chan-
nels in low micromolar concentrations) [23,24]. The ECG was
recorded using an Animal BioAmp ampliﬁer (Lab/8s, ADIn-
struments, Oxford, UK).
Drugs
Acetylcholine (ACh; as chloride salt), indomethacin, NG-nitro-
L-arginine, NS309 (3-oxime-6,7-dichloro-1H-indole-2,3-dione)
and ruthenium red were from Sigma–Aldrich, UK. Apaminwas from Latoxan, USA, and 1-[(2-chlorophenyl) diphenyl-
methyl]-1H-pyrazole (TRAM-34) from Enzo Life Sciences,
UK.
Data analysis
All values are given as mean ± SEM. The number of animals
is given by n. Data were analysed using analysis of variance
(ANOVA) (GraphPad Prism software, version 4) followed
by a Bonferroni’s post hoc-test, where applicable. P values of
less than 0.05 were considered to indicate statistically signiﬁ-
cant differences.
Results
Glucose level and body weight
About threefold higher levels of glucose were measured in
STZ-treated rats (diabetic rats) in comparison with untreated
controls (Table 1). By contrast, insulin levels were signiﬁcantly
lower in diabetic rats. An approximately 40% reduction in
body weight was observed in the latter (Table 1). Assessment
of a potential cardiac hypertrophy induced by diabetes, as
determined by the heart to body weight ratio, was negative
(Table 1). The liver and lung to body weight ratios were not
signiﬁcantly changed.
Blood pressure
No signiﬁcant changes were observed in diastolic and mean
blood pressure (BP). In contrast, signiﬁcant increases in heart
rate (HR), systolic were observed (Table 2).
Relaxations
Acetylcholine
ACh induced a concentration-dependent relaxation of mesen-
teric arteries from control rats (108–105 M). ACh at 1 lM
concentration (which produced submaximal relaxation of con-
trol arteries) was decreased by 75% in mesenteric arteries from
STZ-diabetic rats (Fig. 1a, Table 3). ACh-induced relaxation
mediated by IKCa (in the presence of 100 nM apamin to block
SKCa channel activity) [25] was signiﬁcantly reduced in dia-
betic arteries in comparison with controls (Fig. 1b, Table 3).
Similarly, in the presence of 1 lM TRAM-34 (to block IKCa
Table 2 Blood pressure parameters in control and diabetic
rats (n= 25). Data expressed as mean ± SEM.
Control Diabetics
HR (beats/min) 340.8 ± 6.4 383.3 ± 10.0*
Diastolic pressure (mmHg) 84.9 ± 2.5 92.4 ± 6.2
Systolic pressure (mmHg) 126.8 ± 2.8 148.0 ± 7.5*
Mean pressure (mmHg) 96.2 ± 1.7 110.9 ± 8.5
* Signiﬁcantly different from the control rats (unpaired t test,
P< 0.05).
378 M. Absi et al.channel activity and reveal SKCa-mediated responses) [26,27],
the relaxation to ACh was reduced by 80% (Fig. 1c, Table
3). In the presence of TRAM-34 plus apamin, ACh-induced
relaxation was completely abolished in diabetic but in control
arteries (10.3 ± 7.1%; n= 4).
Ns309
NS309 induced a concentration-dependent relaxation of mes-
enteric arteries from control rats (108–105M). It was used
at 1 lM concentration which produced submaximal relaxation
of control arteries. This concentration is well below the IC50
(10 lM) reported to inhibit voltage-dependent calcium chan-
nels in urinary bladder smooth muscle cells [28].
NS309-mediated relaxations were reduced by approxi-
mately 60% in arteries from diabetic rats (Fig. 2a, Table 3).
In the presence of 100 nM apamin, the relaxation to 1 lMFig. 1 Changes (in%) of the EDHF-mediated relaxation of mesenteri
(1 lM) induced relaxation of mesenteric arteries from control rats w
presence of 100 nM apamin (B) and SKCa response, in presence of 1
produced a decrease in the response to ACh in arteries from both con
SKCa (C) -mediated responses. Results shown are means ± s.e.meanNS309 was decreased (Fig. 2b, Table 3). A reduction in the re-
sponse to NS309 in the presence of 1 lM TRAM-34 was also
observed in diabetic arteries in comparison with controls
(Fig. 2c, Table 3).
We then tested whether the impairment of EDHF-type
relaxation involves dysfunction of Ca2+ inﬂux mechanism
mainly via TRP channels.
(a) The application of 1 lM ruthenium red (non-selective
blocker of TRP channel blocker [29]) reduced the relax-
ant effect of ACh (Fig. 1a), suggesting an involvement of
these channels in EDHF-mediated relaxation of mesen-
teric arteries. ACh-mediated relaxations in the presence
of 100 nM apamin (Fig. 1b) or in the presence of 1 lM
TRAM-34 (Fig. 1c) were not affected by ruthenium red.
In the presence of both TRAM-34 and apamin the remain-
ing relaxant response to ACh (10.3 ± 7.1%; n= 4) was not
affected by ruthenium red (9.1 ± 2.3%; n= 4).
Ruthenium red did not produce any effect when applied
alone indicating the absence of non-speciﬁc effects on endothe-
lial or smooth muscle cells at the concentration used.
The above results do not exclude the possibility that Ca2+
inﬂux through TRP channels is involved in the activation of
KCa channels and consequently the EDHF response. There-
fore, a selective opener of IKCa and SKCa channels (NS309)
was used [30].c arteries in control and diabetic rats in response to ACh. (A) ACh-
as signiﬁcantly reduced in diabetics. The IKCa response, in the
lM TRAM-34 (C), were also affected by diabetes. RuR (1 lM)
trol and diabetic animals (A) but did not affect either IKCa (B) or
(nP 5). One-way ANOVA; \P< 0.05 was considered signiﬁcant.
Table 3 Changes (in%) of the EDHF- [induced by 1 lMACh or 1 lMNS309, +1 lM TRAM-34, +100 nM apamin in the presence
the (+) and in the absence () of 1 lM ruthenium red] mediated relaxations of mesenteric arteries from control and diabetic rats. Data
expressed as mean ± SEM.
Ruthenium red Controls (n) Diabetics (n)
ACh
ACh  84.8 ± 2.8% (8) 22.5 ± 5.8%* (10)
+TRAM-34  55.5 ± 3.7% (5) 10.8 ± 3.5%* (6)
+apamin  31.1 ± 3.3% (5) 9.5 ± 2.5%* (6)
ACh + 50.6 ± 8.7%§ (4) 15.7 ± 3.3% (5)
+TRAM-34 + 50.7 ± 11.3% (4) 12.5 ± 2.3% (5)
+apamin + 30.0 ± 9.0% (5) 10.6 ± 2.7% (6)
NS309
NS309  78.5 ± 8.7%* (5) 32.1 ± 5.8%* (6)
+TRAM-34  27.0 ± 4.4%* (5) 14.8 ± 2.7%* (6)
+apamin  52.6 ± 8.9%* (4) 25.4 ± 5.7%* (5)
NS309 + 39.9 ± 9.5%§ (5) 19.8 ± 3.6%§ (5)
+TRAM-34 + 13.9 ± 4.0%§ (5) 8.2 ± 0.7%§ (5)
+apamin + 16.6 ± 1.0%§ (5) 8.9 ± 0.3%§ (5)
* Signiﬁcantly different from the ACh or NS309 response in the mesenteric arteries from control rats (Bonferroni’s test, P< 0.001).
§ Signiﬁcantly different from the ACh or NS309 response in the mesenteric arteries from control and diabetic rats after treatment with
ruthenium red (Bonferroni’s test, P< 0.05).
Fig. 2 Changes (in%) of NS309-induced responses of mesenteric arteries from control and diabetic rats in response to NS309. (A)
NS309 (1 lM)-induced relaxations were reduced in diabetics arteries. The IKCa response, in the presence of 100 nM apamin (B) and the
SKCa response, in presence of 1 lM TRAM-34 (C) were also affected by diabetes. Relaxations of arteries mediated by NS309, opening of
IKCa (B) or SKCa (C) were markedly reduced by RuR. Results shown are means ± s.e.mean (nP 5). One-way ANOVA;
\P< 0.05 was
considered signiﬁcant.
EDHF-mediated responses in diabetic rats 379(a) Ruthenium red application resulted in a signiﬁcant
decrease in relaxation toNS309 (Fig. 2a). The application
of ruthenium red reduced the relaxant response of 1uMNS309 in the presence of 100 nM apamin (Fig. 2b). A
similar reduction in relaxation to NS309 was also
detected in the presence of 1 lM TRAM-34 (Fig. 2c).
380 M. Absi et al.Electrocardiograms parameters of isolated heartsThere was no signiﬁcant alteration in P duration, QT interval
and QRS interval between hearts from control and diabetic
rats (Table 4). The application of NO and COX inhibitors
(to reveal EDHF pathway) before and after treatment with
1 lM ruthenium red was not accompanied by a change in
the above ECG parameters (Table 4). Similarly, ST and T
wave amplitude was not signiﬁcantly changed between groups
studied. However, a signiﬁcant decrease in PR interval was ob-
tained in hearts isolated from control rats after the infusion of
NO and COX inhibitors. In addition, following the application
of ruthenium red a signiﬁcant decrease in PR interval and R
amplitude was observed in diabetic hearts in comparison with
diabetic hearts that were infused with NO and COX inhibitors
(Table 4).
Discussion
In mesenteric arteries from control rats, ACh produced a
relaxation which was largely due to the opening of SKCa chan-
nels. In control arteries, the relaxant response to ACh required
the opening of both IKCa and SKCa channels as evident by sig-
niﬁcant reduction in the relaxation induced by ACh in the
presence of both TRAM-34 plus apamin. The remaining
ACh response could be to due to the involvement of additional
pathways (independent of endothelial hyperpolarization). An
example is the release of epoxyeicosatrienoic acids (EETs) act-
ing on the potassium channels located on the smooth muscle
cells [5]. In contrast, in diabetic arteries the ACh-induced
relaxation appeared to be due to EDHF, since ACh failed to
produce any response in the presence of TRAM-34 and apam-
in. This indicates that the contribution of EDHF relaxation of
small arteries is becoming more important in pathological con-
ditions. These results are in agreement with recent ﬁndings by
Leo et al. [12] who showed that endothelium-dependent relax-
ation was abolished in diabetic arteries, but only slightly atten-
uated in normal arteries.
The induction of diabetes impaired the EDHF pathway in
response to ACh. In the presence of either TRAM-34 or apam-
in, SKCa or IKCa- mediated relaxations in response to ACh
were also compromised in mesenteric arteries from diabetic
rats. Our results are in agreement with previous ﬁndings
[10,12]. It is possible that the impairment of the EDHF re-
sponse and KCa-mediated relaxation of mesenteric arteries
contribute to the development of elevated systolic blood pres-Table 4 Summary of ECG parameters of the hearts obtained from
NO and cyclooxygenase inhibitors (EDHF) and NO and cyclooxyge
Data expressed as mean ± SEM.
Controls Diabetics EDHF-C
P duration (ms) 15.3 ± 2.8 19.10 ± 1.4 16.8 ± 0.00
QT interval (ms) 56.4 ± 3.8 54.4 ± 4.6 62.4 ± 5.6
PR interval (ms) 44.1 ± 4.2* 30.7 ± 4.7 14.6 ± 3.9*
QRS interval (ms) 24.7 ± 1.9 23.8 ± 3.1 29.4 ± 5.9
ST amplitude (mV) 0.18 ± 0.01 0.12 ± 0.01 0.39 ± 0.09
T amplitude 0.35 ± 0.16 0.28 ± 0.02 0.21 ± 0.06
R amplitude 1.56 ± 0.55 0.78 ± 0.12 1.03 ± 0.23
* Signiﬁcantly different from the corresponding control (P< 0.05).sure observed in this study, since these arteries are considered
to play an important role in regulating blood pressure [30].
Previous studies [10,12] showed that the most commonly
observed effect in the resistance arteries is a reduced respon-
siveness to the endothelium dependent vasodilator ACh [10]
which induces the activation of endothelial KCa channels by
a global increase in [Ca2+]i [13,14]. This led us test the follow-
ing hypothesis:
Is the impairment of SKCa or IKCa- mediated relaxation in
response to ACh (and consequently the EDHF response) is
due to impairment of global increase in [Ca2+]i which will
in turn affect the activity of KCa channels or is it due to
the compromised function of the KCa channels per se?
In order to address this possibility, NS309 (a direct opener
of KCa channels) was used. Results showed that NS309 in-
duced a relaxation of mesenteric arteries from control rats.
The response to NS309 was largely attenuated in diabetic rats.
In addition, SKCa or IKCa- mediated relaxation in response to
NS309 was also reduced in diabetics. This indicates that
impairment of the EDHF response is due to dysfunction of
SKCa or IKCa channels.
It was also observed that NS309, which acts by increasing
the channel sensitivity for Ca2+, appears to produce its relax-
ant response largely via IKCa channels. This is in agreement
with study by Strobaek et al. [15] and consistent with results
of a study in rat mesenteric arteries and human umbilical vein
endothelial cells in which IKCa channels play the prominent
role with respect to the response to NS309 [27].
Is the impairment of the EDHF relaxation in response to
ACh or NS309 is related to a change in the Ca2+ inﬂux
mechanism required for the activation of KCa channels?
In order to test this possibility, we examined the EDHF-
mediated relaxation of mesenteric arteries from control and
diabetic rats in the presence of ruthenium red which is a non-
selective blocker of TRP channels. These are considered one
of the main pathways for Ca2+ entry into the endothelial cells.
Results showed that ACh- and NS309 produced relaxations
were inhibited by ruthenium red. This suggests that TRP chan-
nels are involved in the EDHF-mediated relaxation in response
to ACh, or via NS309. Ruthenium red also reduced EDHF-
mediated relaxation induced by ACh and NS309 in mesenteric
arteries from diabetic rats, which suggests that TRP-mediated
dilatations of those arteries are also impaired.control and diabetic rats without and following treatment with:
nase inhibitors +1 lM ruthenium red [EDHF+ RuR] (n= 5).
EDHF-D EDHF-C+ RuR EDHF-D+ RuR
1 20.4 ± 0.004 20.4 ± 0.6 8.82 ± 0.002
59.1 ± 8.6 62.4 ± 5.5 51.2 ± 12.4
32.8 ± 0.008* 14.6 ± 3.9 16.1 ± 2.9*
25.1 ± 2.7 29.4 ± 5.9 32.2 ± 10.1
0.14 ± 0.07 0.13 ± 0.02 0.08 ± 0.03
0.16 ± 0.02 0.22 ± 0.01 0.05 ± 0.001
0.62 ± 0.12* 0.42 ± 0.12 0.018 ± 0.006*
EDHF-mediated responses in diabetic rats 381Ruthenium red did not affect IKCa or SKCa induced relax-
ations of mesenteric arteries caused by ACh whereas it mark-
edly reduced those produced by NS309. This strongly indicates
that above) and indicates that impairment of the EDHF re-
sponse is due to compromised opening of KCa channels. It is
also possible that the activation of TRP channels leads to dila-
tation of arteries via a mechanism which involves direct open-
ing of endothelial IKCa and SKCa channels, most likely
associated with a near-membrane rather than a global increase
in [Ca2+]i [14,16,31]; see Fig. 3. Thus, it is possible that these
channels may provide and maintain some level of [Ca2+]i that
is necessary for the activation of endothelial IKCa and SKCa by
NS309 (see Fig. 3). This direct interaction between KCa and
TRP channels and the resulting adequate levels of [Ca2+]i
are possibly impaired in diabetes.
This interpretation is in agreement with the results of Ear-
ley et al. [32] in rat cerebral arteries. They showed that Ca2+
inﬂux via TRPA1 (which co-localizes with KCa3.1) produces
a vasodilatation by a mechanism involving the opening of
endothelial cell IKCa and SKCa channels [32]. Another channel
of the TRP family, TRPV4, produces EDHF-mediated vasodi-
latation in small-sized Arteria gracilis vessels, in which EDHF
plays a signiﬁcant role [24].
It is unlikely that TRP channels-mediated relaxation of
mesenteric arteries from control rats is due the opening of
K+ channels that are located on vascular smooth muscle cells
since ruthenium red did not change the relaxant response to
ACh following the blockade of endothelial KCa channels.
Is there any effect of STZ-induced diabetes on the function
of rat hearts?
The most known metabolic disturbance associated with
STZ-induced diabetes is hypothyroidism [33–35]. This was
linked to cardiovascular disturbances [34], whereas other stud-
ies showed no effect of hypothyroidism on diabetes-inducedFig. 3 Summary of suggested pathways for the activation of KCa cha
[Ca2+]i as a consequence of Ca
2+ release from inositol trisphosphat
[Ca2+]i triggers the activation of IKCa and SKCa and consequently th
triggers Ca2+ entry via TRP channels, which consequently participates
close vicinity to TRP channels. The opening of TRP channels maintain
KCa channels to be activated by NS309 (2).cardiac dysfunction [36,37]. However, in a study by Ramanad-
ham et al. [38], cardiac dysfunction was observed in diabetic
rats in the absence of hypothyroidism.
Zhang et al. [39] reported that, in contrary to previous stud-
ies, streptozotocin-induced diabetes protected the ex vivo heart
against ischemia–reperfusion induced arrhythmias. They ob-
served signs of clinical hypothyroidism (including decreased
heart rate, prolonged QT interval and decreased rectal temper-
ature) in STZ-diabetic rats. These signs were absent from our
study. Moreover, there was no change in ECG parameters in
hearts isolated from STZ-diabetic rats in comparison with
those obtained from control rats which exclude the possibility
that STZ is associated with metabolic disturbances that affect
cardiac function.
Our data showed a signiﬁcant weight loss in STZ-diabetic
rats despite the fact that these animals exhibited normal food
intake and grooming. Weight loss also does not seem to affect
cardiac function as evident by comparable ECG parameters
(such as P duration and PR interval) between control and
STZ-rats. The weight loss in STZ-diabetic rats observed in
our study is in agreement with previous ﬁndings by Wang
et al. [40] in which STZ-induced weight loss was attributed
to reduction in adipose tissue mass and gene expression of pro-
teins that play important role in the regulation of adipocytes
and adipose tissue function including leptin and adiponectin
receptors.
Is there any role of the EDHF in the regulation of cardiac
function in control and diabetic hearts?
Both endothelial KCa channels have high sensitivity to
[Ca2+]i. which leads to the expectation that the opening of
these channels (and consequently the generation of EDHF)
may affect Ca2+ handling, cardiac repolarisation and hence
the electrical conduction of the cardiac myocytes [41]. In
the presence of NO and COX inhibitors (in order to revealnnels and generation of EDHF. ACh leads to a global increase in
e (IP3) sensitive Ca
2+ stores within endothelial cells. The rise in
e generation of EDHF response. Depletion of intracellular stores
in the global increase of [Ca2+]i.(1). KCa are possibly localized in
s some level of localized increase in [Ca2+]i, which is essential for
382 M. Absi et al.the EDHF pathway), the P wave duration (which represents
the wave of depolarization of the atria that is created by
sino-atrial nodal action potentials) [42] remained unchanged
which indicates that EDHF does not contribute to the propa-
gation of the action potential through the atria.
After atrial activation the action potentials reach the atrio-
ventricular node and His bundle and the time during which
they are activated corresponds the PR interval on the ECG
[42]. In our study, the observed decrease in PR interval in
hearts isolated from control rats, indicates that under normal
conditions EDHF may contribute to the regulation of atrio-
ventricular conduction.
NO and COX inhibitors had no signiﬁcant effect on the
duration of QRS complex (which represents the propagation
of the action potential through the ventricles) [42]. The QT
interval (representing the time for ventricular depolarization
and repolarisation to occur) [42] was also not changed after
the application of NO and COX inhibitors which suggest that
EDHF does no contribute to the rate of propagation of exci-
tation in the perfused rat heart. Since Ca2+ inﬂux is essential
for the activation of KCa channels and the EDHF response,
we tested the effect of TRP channels inhibition (in the presence
of both NO and COX inhibitors plus RuR) on the function of
hearts from control and diabetic rats.
The inhibition of TRP channels seem to shorten the PR
interval and decrease the R wave amplitude in diabetic hearts.
These changes indicate that TRP channels may have a role in
the regulation of the electrical conduction through the AV
node as well as intraventricular conduction particularly in dia-
betes. Indeed, a recent study on the developing chick heart
showed that TRPC channels have a role in the regulation ven-
tricular activity and their inhibition leads to ventricular
arrhythmias [43]. However, other ECG parameters were com-
parable between control and diabetic hearts in the presence
and absence of NO and COX inhibitors and ruthenium red.
Future studies are needed to elucidate the type of KCa and/
or TRP channels involved in there regulation of cardiac electri-
cal activity in isolated myocytes.
There are other important questions that remain to be an-
swered including which TRP channel/s are involved in the
EDHF response and whether the function and/or protein
expression of these channels are also affected by diabetes.
Conclusion
The results of the present study demonstrate: (1) the impair-
ment of EDHF-mediated relaxation of rat mesenteric arteries
with streptozotocin-induced diabetes; (2) diabetes affects the
direct opening of both IKCa and SKCa channels; (3) a possible
involvement of TRP channels in the EDHF-mediated relaxa-
tion of rat mesenteric arteries; (4) TRP-induced relaxations
are likely mediated via the opening of endothelial KCa channels
and are affected by diabetes (5) the EDHF response is possibly
involved in the regulation of the electrical conduction between
the atria and the ventricles in hearts from control rats. In con-
trast, TRP channels are more important in diabetic state and
may be play a role in the regulation of ventricular activity of
the heart.
Based on the ﬁndings of the resent study, it is possible that
KCa-mediated EDHF response and TRP channels could pro-
vide potential therapeutic targets for the treatment of cardio-
vascular complications associated with diabetes.Acknowledgments
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